SCHEMBL740809

SCHEMBL740809

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccncc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.52
ABL1 P00519 2/20 0.50
BCR P11274 2/20 0.50
CDK2 P24941 2/20 0.47
MAP4K4 O95819 1/20 0.47
CDK1 P06493 1/20 0.47
CLK2 P49760 1/20 0.47
GSK3B P49841 1/20 0.47
CSNK2A1 P68400 1/20 0.47
CDK5 Q00535 1/20 0.47
MAP4K2 Q12851 1/20 0.47
CAMK2B Q13554 1/20 0.47
CAMK2G Q13555 1/20 0.47
CAMK2D Q13557 1/20 0.47
DYRK1A Q13627 1/20 0.47
PIM3 Q86V86 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
SGK2 Q9HBY8 1/20 0.47
MAP4K5 Q9Y4K4 1/20 0.47
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.94 AURKA (0.55) AURKAABL1BCRCDK2CDK7
SCHEMBL740955 0.90 CDK7 (0.48) AURKAABL1BCRCDK2MAPK1
SCHEMBL738866 0.89 AURKA (0.53) AURKAABL1BCRCDK2MAP4K4
SCHEMBL741311 0.89 AURKA (0.53) AURKAABL1BCRCDK2CLK2
SCHEMBL741609 0.88 AURKA (0.52) AURKAABL1BCRCDK2CSNK2A1
SCHEMBL739779 0.88 AURKA (0.52) AURKAABL1BCRROCK2ROCK1
SCHEMBL1779700 0.88 AURKA (0.50) AURKAABL1BCRHTT
SCHEMBL741926 0.88 AURKA (0.52) AURKAABL1BCRCDK2MAP4K4
SCHEMBL743719 0.87 ABL1 (0.55) AURKAABL1BCRIMPDH2ROCK2
SCHEMBL739853 0.87 AURKA (0.51) AURKAABL1BCRCDK7IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed